Skip to main content
SpringerLink
Log in

Substance Abuse and Respiratory Disease

  • Chapter
Substance Abuse

  • 2354 Accesses

Abstract

Inhalation of substances of abuse is an efficient way of delivering a high concentration of drug to their target organ, the brain, and it is unsurprising that smoking is a popular mode of drug abuse. In this chapter, we discuss tobacco smoking, its effects on patients and therapies to help patients quit tobacco smoking. In addition, we review the effects of other drugs on the lung, including marijuana, cocaine, alcohol, benzodiazepines, and heroin.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. http://www.drugabuse.gov/related-topics/trends-statistics. Accessed 1 Sept 2013.

  2. Substance Abuse and Mental Health Services Administration. Results from the 2010 National Survey on Drug Use and Health: summary of National Findings, NSDUH series H-41, HHS publication no. (SMA) 11-4658. Rockville: Substance Abuse and Mental Health Services Administration; 2011.

    Google Scholar 

  3. Ockene IS, Houst Miller N, For the American Heart Association Task Force on Risk Reduction. Cigarette smoking, cardiovascular disease, and stroke. Circulation. 1997;96:3243–7.

    Article  CAS  PubMed  Google Scholar 

  4. Jarvis MJ. Why do people smoke. BMJ. 2004;328(7433):277–9.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Benowitz NL. Nicotine addiction. N Engl J Med. 2010;362(24):2295–303.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Edwards R. The problem of tobacco smoking. BMJ. 2004;328(7433):217–9.

    Article  PubMed Central  PubMed  Google Scholar 

  7. West R. Assessment of dependence and motivation to stop smoking. BMJ. 2004;328(7433):338–9.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Coleman T. Use of simple advice and behavioural support. BMJ. 2004;328(7433):397–9.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Fiore MC, Jaen CR, Baker TB, Bailey WC, et al. Treating tobacco use and dependence: 2008 update. Rockville: US Department of Health and Human Services, Public Health Service; 2008.

    Google Scholar 

  10. Hurt RD, Sachs DPL, Glover ED, Offord KP, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med. 1997;337:1195–202.

    Article  CAS  PubMed  Google Scholar 

  11. Oeltmann JE, Oren E, Haddad MB, Lake LK, Harrington TA, Ijaz K, Narita M. Tuberculosis outbreak in marijuana users, Seattle, Washington, 2004. Emerg Infect Dis. 2006;12(7):1156–9.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Aldington S, Harwood M, Cox B, Weatherall M, Beckert L, Hansell A, Pritchard A, Robinson G, Beasley R. Cannabis and the risk of lung cancer: a case-control study. Eur Respir J. 2008;31(2):280–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Roth MD, Arora A, Barsky SK, Kleerup EC, Simmons M, Tashkin DP. Airway inflammation in young marijuana and tobacco. Am J Respir Crit Care Med. 1998;157(3):928–37.

    Article  CAS  PubMed  Google Scholar 

  14. Tashkin DP, Coulson AH, Clark VA, Simmons M, Bourque LB, Duann S, Spivey GH, Gong H. Respiratory symptoms and lung function in habitual heavy smokers or marijuana alone, smoker of marijuana and tobacco, smoker of tobacco alone, and nonsmokers. Am Rev Respir Dis. 1987;135(1):209–16.

    CAS  PubMed  Google Scholar 

  15. Tetrault JM, Crothers K, Moore BA, Mehra R, Concato J, Fiellin DA. Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch Intern Med. 2008;167(3):221–8.

    Article  Google Scholar 

  16. Tashkin DP, Simmons MS, Tseng CH. Impact of changes in regular use of marijuana and or/tobacco on chronic bronchitis. COPD. 2012;9(4):367–74.

    PubMed  Google Scholar 

  17. Pletcher MJ, Vittinghoff E, Kalhan R, Richman J, Safford M, Sidney S, Ling F, Keresz S. Association between marijuana exposure and pulmonary function tests over 20 years. JAMA. 2012;307(2):173–81.

    Article  CAS  PubMed  Google Scholar 

  18. Aldington S, Williams M, Nowitz M, Weatherall M, Pritchard A, McNaughton A, Robinson G, Beasley R. Effects of cannabis on pulmonary structure, function and symptoms. Thorax. 2007;62(12):1058–63.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Taylor DR, Fergusson DM, Milne BJ, Horwood LJ, Moffitt TE, Sears MR, Poulton R. A longitudinal study of the effects of tobacco and cannabis exposure on lung function in young adults. Addiction. 2002;97(8):1055–61.

    Article  PubMed  Google Scholar 

  20. Johnson MK, Smith RP, Morrison D, Laszlo G, White RJ. Thorax. 2000;55(4):340–2.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Beshay M, Kaiser H, Niedhart D, Remond MA, Smid RA. Emphysema and secondary pneumothorax in young adults smoking cannabis. Eur J Cardiothorac Surg. 2007;32:834–8.

    Article  PubMed  Google Scholar 

  22. Hatsukami DK, Fischman MW. Crack cocaine and cocaine hydrochloride. Are the differences myth or reality. JAMA. 1996;276(19):1580–8.

    Article  CAS  PubMed  Google Scholar 

  23. Kon OM, Redhead JB, Gillen D, Fothergill J, Henry JA, Mitchell DM. Crack lung caused by an impure preparation. Thorax. 1996;51:959–60.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Forrest JM, Steele AW, Waldron JA, Parsons PE. Crack lung: an acute pulmonary syndrome with a spectrum of clinical and histopathological findings. Am Rev Respir Dis. 1990;142(2):462–7.

    Article  Google Scholar 

  25. Restrepo CS, Carrillo JA, Martines S, Ojeda P, Rivera AL, Hatta A. Pulmonary complications from cocaine and cocaine-based substances: imaging manifestations. Radiographics. 2007;27:941–56.

    Article  PubMed  Google Scholar 

  26. Haim DY, Lippman ML, Goldberg SK, Walkenstein MD. The pulmonary complications of crack cocaine. A comprehensive review. Chest. 1995;107(1):233–40.

    Article  CAS  PubMed  Google Scholar 

  27. O’Donnell AE, Mappin FG, Sebo TJ, Tazelaar H. Interstitial pneumonitis associated with “crack” cocaine abuse. Chest. 1991;100(4):1155–7.

    Article  PubMed  Google Scholar 

  28. Abenheim L, Moride Y, Brenot F, Rich S, Benichou J, Kurz X, Higenbottam T, Oakley C, Wouters E, Aubier M, Simonneau G, Begaud B. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med. 1996;335:609–16.

    Article  Google Scholar 

  29. Kershaw CD, Guidot DM. Alcoholic lung disease. NIAAA Publications. http://pubs.niaaa.nih.gov/publications/arh311/66-75.htm.

  30. Kaphalia L, Calhoun WJ. Alcoholic lung injury: metabolic, biochemical and immunological aspects. Toxicol Lett. 2013;222(2):171–9.

    Article  CAS  PubMed  Google Scholar 

  31. Buster MCA, Rook L, Van BRussel GHA, van Ree J. Chasing the dragon, related to the impaired lung function among heroin users. Drug Alcohol Depend. 2002;68(2):221–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Addenbrooke’s Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK

    Martin D. Knolle MA, MB, BChir., PhD, MRCP

  2. Respiratory Department, Peterborough & Stamford Hospitals, Cambridge, UK

    Sumit Chatterji M.A., M.B., B.Chir., F.R.C.P

  3. West Suffolk Hospital, A University of Cambridge Teaching Hospital, Bury St. Edmunds, UK

    Thomas B. Pulimood F.R.C.P., F.H.E.A.

Authors
  1. Martin D. Knolle MA, MB, BChir., PhD, MRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sumit Chatterji M.A., M.B., B.Chir., F.R.C.P
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thomas B. Pulimood F.R.C.P., F.H.E.A.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas B. Pulimood F.R.C.P., F.H.E.A. .

Editor information

Editors and Affiliations

  1. Louisiana State University Health Sciences Center, Louisiana State University Interim Hospital, and Ochsner Kenner Hospital, Departments of Anesthesiology and Pharmacology, New Orleans, Louisiana, USA

    Alan David Kaye

  2. Department of Anesthesiology, Yale University School of Medicine and Yale-New Haven Hospital, New Haven, Connecticut, USA

    Nalini Vadivelu

  3. Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA

    Richard D. Urman

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Knolle, M.D., Chatterji, S., Pulimood, T.B. (2015). Substance Abuse and Respiratory Disease. In: Kaye, A., Vadivelu, N., Urman, R. (eds) Substance Abuse. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1951-2_39

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1951-2_39

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1950-5

  • Online ISBN: 978-1-4939-1951-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation